Oxford Sciences Innovation returned to reinvest in the smart echocardiogram technology spinout, helping increase its overall funding to nearly $60m.

Ultromics, a UK-based cardiovascular imaging technology provider spun out of University of Oxford, secured $33m yesterday in a series B round featuring the university’s venture capital partner, Oxford Sciences Innovation (OSI). The round was led by Blue Venture Fund, a vehicle backed by 35 Blue Cross and Blue Shield Association health insurers, and also featured…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.